Victory Capital Management Inc Bicycle Therapeutics PLC Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$20.37 - $32.9 $163,713 - $264,417	8,037 New	8,037 $237,000
Q3 2022 Nov 02, 2022	BUY	$17.49 - $28.44 $42,763 - $69,535	2,445 Added 7.32%	35,857 $834,000
Q2 2022 Aug 01, 2022	SELL	$12.95 - $46.99 $6.71 Million - $24.3 Million	-518,003 Reduced 93.94%	33,412 $561,000
Q1 2022 May 04, 2022	SELL	$40.12 - $59.5 $688,178 - $1.02 Million	-17,153 Reduced 3.02%	551,415 $23.5 Million
Q4 2021 Feb 07, 2022	BUY	$41.7 - $61.14 $17.3 Million - $25.4 Million	414,845 Added 269.87%	568,568 $34.6 Million
Q3 2021 Nov 02, 2021	SELL	$27.95 - $44.24 $465,423 - $736,684	-16,652 Reduced 9.77%	153,723 $6.39 Million
Q2 2021 Aug 03, 2021	SELL	$27.0 - $32.28 $259,659 - $310,436	-9,617 Reduced 5.34%	170,375 $5.17 Million
Q1 2021 May 04, 2021	BUY	$19.12 - $30.25 $205,387 - $324,945	10,742 Added 6.35%	179,992 $5.38 Million
Q4 2020 Feb 01, 2021	BUY	$17.95 - $21.36 $314,484 - $374,227	17,520 Added 11.55%	169,250 $3.04 Million
Q3 2020 Nov 09, 2020	SELL	$15.3 - $20.8 $854,550 - $1.16 Million	-55,853 Reduced 26.91%	151,730 $2.89 Million
Q2 2020 Aug 07, 2020	SELL	$12.63 - $18.21 $153,467 - $221,269	-12,151 Reduced 5.53%	207,583 $3.23 Million
Q1 2020 May 04, 2020	BUY	$9.82 - $18.0 $827,217 - $1.52 Million	84,238 Added 62.17%	219,734 $3.21 Million
Q4 2019 Feb 06, 2020	SELL	$7.68 - $11.08 $170,027 - $245,300	-22,139 Reduced 14.04%	135,496 $1.28 Million
Q4 2019 Feb 04, 2020	BUY	$7.68 - $11.08 $139,307 - $200,980	18,139 Added 13.0%	157,635 $1.72 Million
Q2 2019 Aug 15, 2019	BUY	$10.06 - $14.63 $1.4 Million - $2.04 Million	139,496 New	139,496 $1.4 Million

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

Baker Bros. Advisors LP New York, NY

9.4M
Shares

$137 Million
2.28% of portfolio
Deep Track Capital, LP Greenwich, CT

3.55M
Shares

$51.8 Million
2.97% of portfolio
Fcpm Iii Services B.V. Naarden, P7

2.34M
Shares

$34.2 Million
9.09% of portfolio
Ra Capital Management, L.P. Boston, MA

2.25M
Shares

$32.9 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

1.96M
Shares

$28.6 Million
0.74% of portfolio

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account